German Medical Devices Act
This article was originally published in The Gray Sheet
Executive Summary
Second amendment expanding surveillance of device reprocessing will go into effect in January, following passage by the German parliament. The law requires standard conformity assessment of reprocessed devices if the products are not returned by the third party to the original user. Additionally, external reprocessors will be incorporated into CA surveillance systems and be obligated to register any reprocessed devices. Advertising regulations will be modified under the amendment, which also addresses Internet advertising and the creation of a patient-oriented information policy...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.